Search
Inogen Inc
INGNAdd to Watchlist
6.410USD
+0.040+0.63%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
175.41MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Inogen Inc is 8.00, ranking 66 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 13.00, with a high of 14.00 and a low of 12.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
12.000
Target Price
+88.38%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Inogen Inc
INGN
3
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Inogen Inc's expected revenue for the next quarter?
Inogen Inc's expected revenue is 95.23M.
What is Inogen Inc's price target?
Analysts forecast that Inogen Inc's price target is USD 13.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 12.00.
How have Inogen IncINGN's recent earnings per share performed?
The market expectation was USD -0.30, while Inogen IncINGN's earnings per share (EPS) for the previous quarter was USD -0.26. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for Inogen Inc?
Based on the ratings of Inogen Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
